Guardion Health Sciences, Inc.
GHSIDelisted Oct 11, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001642375
Guardion Health Sciences, Inc. was delisted on Oct 11, 2024; its insiders filed their last Form 4 on Aug 28, 2024; 15 institutions reported holding it in 13F filings for Q3 2024, worth $587.7K in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Guardion Health Sciences, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 13 | 14 | +1 |
| Shares | 49.8K | 67.5K | +17.7K (+35.5%) |
| Value | $387.4K | $497.7K | +$110.3K (+28.5%) |
New holders (4)
Institutions that held Guardion Health Sciences, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Group Inc | 14,852 | $109.6K | 0.00% |
| Tower Research Capital LLC (TRC) | 967 | $7.14K | 0.00% |
| Bank of America Corp | 18 | $133 | 0.00% |
| Royal Bank of Canada | 2 | $0 | 0.00% |
Sold out (3)
Institutions that held Guardion Health Sciences, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| UBS Group AG | 43 | $335 |
| Roffman Miller Associates Inc | 40 | $311 |
| Impact Partnership Wealth, LLC | 10 | $78 |